A novel biliary stent loaded with 125I seeds in patients with malignant biliary obstruction: Preliminary results versus a conventional biliary stent

Journal of Hepatology

Volumn 56, Issue 5, 2012, Pages 1104-1111

  Zhu, Hai Dong ^a   Guo, Jin He ^a   Zhu, Guang Yu ^a   He, Shi Cheng ^a   Fang, Wen ^a   Deng, Gang ^a   Qin, Yong Lin ^a   Li, Guo Zhao ^a   Coldwell, Douglas M ^b   Teng, Gao Jun ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b UNIVERSITY OF LOUISVILLE HOSPITAL   (United States)

Author keywords

Biliary obstruction; Brachytherapy; Cancer; Stents

Indexed keywords

IODINE 125; NITINOL;

ABDOMINAL PAIN; ADENOCARCINOMA; ADULT; AGED; ARTICLE; BILE DUCT OBSTRUCTION; BILE DUCT PERFORATION; BILIARY INTRALUMINAL IRRADIATION STENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE THERAPY; FEMALE; HEMOBILIA; HUMAN; IN-STENT RESTENOSIS; IRRADIATION; MALE; MALIGNANT BILIARY OBSTRUCTION; OBSTRUCTIVE JAUNDICE; OVERALL SURVIVAL; PALLIATIVE THERAPY; PERFORATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STENT; SURVIVAL TIME; TREATMENT RESPONSE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BILIARY TRACT NEOPLASMS; CHOLESTASIS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IODINE RADIOISOTOPES; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOTHERAPY; RETROSPECTIVE STUDIES; SINGLE-BLIND METHOD; STENTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84862793588     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.12.018     Document Type: Article

References (38)

1. Bismuth H, Castaing D, Traynor O. Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg 1988;12:39-47. (Pubitemid 18074502)
2. Stain SC, Baer HU, Dennison AR, Blumgart LH. Current management of Hilar cholangiocarcinoma. Surg Gynecol Obstet 1992;175:579-588.
3. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005;366:1303-1314. (Pubitemid 41416587)
4. Petrowsky H, Hong JC. Current surgical management of hilar and intrahepatic cholangiocarcinoma: the role of resection and orthotopic liver transplantation. Transplant Proc 2009;41:4023-4035.
5. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249.
6. Larghi A, Tringali A, Lecca PG, Giordano M, Costamagna G. Management of hilar biliary strictures. Am J Gastroenterol 2008;103:458-473. (Pubitemid 351248725)
7. Covey AM, Brown KT. Palliative percutaneous drainage in malignant biliary obstruction. Part 1: indications and preprocedure evaluation. J Support Oncol 2006;4:269-273. (Pubitemid 44203630)
8. Moss AC, Morris E, Leyden J, MacMathuna P. Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results. Cancer Treat Rev 2007;33:213-221. (Pubitemid 46343103)
9. Teng GJ, Guo JH, Zhu GY, He SC, Deng G, He J. Self-expandable stent loaded with I-125 seeds: feasibility and safety in a rabbit model. Eur J Radiol 2007;61:356-361. (Pubitemid 46096692)
10. Teng GJ, Guo JH, Zhu GY, He SC, Fang W, Deng G, et al. Self-expandable esophageal stent loaded with I-125 seeds: initial experience in patients with advanced esophageal cancer. Radiology 2008;247:574-581.
11. Kullman E, Frozanpor F, Soderlund C, Linder S, Sandstrom P, Lindhoff-Larsson A, et al. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc 2010;72:915-923.
12. Isayama H, Komatsu Y, Tsujino T, Sasahira N, Hirano K, Toda N, et al. A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction. Gut 2004;53:729-734. (Pubitemid 38561453)
13. Weber A, Mittermeyer T, Wagenpfeil S, Schmid RM, Prinz C. Self-expanding metal stents versus polyethylene stents for palliative treatment in patients with advanced pancreatic cancer. Pancreas 2009;38:e7-e12.
14. Wolpin BM, Mayer RJ. A step forward in the treatment of advanced biliary tract cancer. N Engl J Med 2010;362:1335-1337.
15. Chahal P, Baron TH. Cholangiocarcinoma. Curr Treat Options Gastroenterol 2005;8:493-502. (Pubitemid 43056146)
16. Roy R, Maraveyas A. Chemoradiation in pancreatic adenocarcinoma: a literature review. Oncologist 2010;15:259-269.
17. Kopek N, Holt MI, Hansen AT, Hoyer M. Stereotactic body radiotherapy for unresectable cholangiocarcinoma. Radiother Oncol 2010;94:47-52.
18. van der Gaag NA, Rauws EA, van Eijck CH, Bruno MJ, van der Harst E, Kubben FJ, et al. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med 2010;362:129-137.
19. Huggett MT, Ghaneh P, Pereira SP. Drainage and bypass procedures for palliation of malignant diseases of the upper gastrointestinal tract. Clin Oncol (R Coll Radiol) 2010;22:755-763.
20. Killeen RP, Harte S, Maguire D, Malone DE. Achievable outcomes in the management of proximal cholangiocarcinoma: an update prepared using ''evidence-based practice'' techniques. Abdom Imaging 2008;33:54-57.
21. Song TJ, Lee SS, Yun SC, Park do H, Seo DW, Lee SK, et al. Paclitaxel-eluting covered metal stents versus covered metal stents for distal malignant biliary obstruction: a prospective comparative pilot study. Gastrointest Endosc 2011;73:727-733.
22. Covey AM, Brown KT. Palliative percutaneous drainage in malignant biliary obstruction. Part 2: mechanisms and postprocedure management. J Support Oncol 2006;4:329-335. (Pubitemid 44420135)
23. Simmons DT, Baron TH, Petersen BT, Gostout CJ, Haddock MG, Gores GJ, et al. A novel endoscopic approach to brachytherapy in the management of Hilar cholangiocarcinoma. Am J Gastroenterol 2006;101:1792-1796. (Pubitemid 44166588)
24. Nag S, DeHaan M, Scruggs G, Mayr N, Martin EW. Long-term follow-up of patients of intrahepatic malignancies treated with iodine-125 brachytherapy. Int J Radiat Oncol Biol Phys 2006;64:736-744. (Pubitemid 43183568)
25. Shinohara ET, Guo M, Mitra N, Metz JM. Brachytherapy in the treatment of cholangiocarcinoma. Int J Radiat Oncol Biol Phys 2010;78:722-728.
26. Chen Y, Wang XL, Yan ZP, Wang JH, Cheng JM, Gong GQ, et al. The use of (125)I seed strands for intraluminal brachytherapy of malignant obstructive jaundice. Cancer Biother Radiopharm 2011, [Epub ahead of print].
27. Indar AA, Lobo DN, Gilliam AD, Gregson R, Davidson I, Whittaker S, et al. Percutaneous biliary metal wall stenting in malignant obstructive jaundice. Eur J Gastroenterol Hepatol 2003;15:915-919. (Pubitemid 36904462)
28. van Delden OM, Lameris JS. Percutaneous drainage and stenting for palliation of malignant bile duct obstruction. Eur Radiol 2008;18:448-456. (Pubitemid 351248176)
29. Liu Y, Lu Z, Zou DW, Jin ZD, Liu F, Li SD, et al. Intraluminal implantation of radioactive stents for treatment of primary carcinomas of the peripancreatic-head region: a pilot study. Gastrointest Endosc 2009;69:1067-1073.
30. Liu Y, Liu JL, Cai ZZ, Lu Z, Gong YF, Wu HY, et al. A novel approach for treatment of unresectable extrahepatic bile duct carcinoma: design of radioactive stents and an experimental trial in healthy pigs. Gastrointest Endosc 2009;69:517-524.
31. Montemaggi P, Morganti AG, Dobelbower Jr RR, Brizi G, Smaniotto D, Costamagna G, et al. Role of intraluminal brachytherapy in extrahepatic bile duct and pancreatic cancers: is it just for palliation? Radiology 1996;199:861-866. (Pubitemid 26157497)
32. McDermott CE, Gengozian N. The effect of low exposure-rate gamma irradiation on T and B lymphocyte function in the mouse. Int J Radiat Biol Relat Stud Phys Chem Med 1980;37:415-428. (Pubitemid 10091464)
33. Serhatlioglu S, Ogur E, Ozan AT, Gursu F, Godekmerdan A, Ayar A. Biochemical and immunological effects of ionizing radiation in radiology staff members. Tani Girisim Radyol 2004;10:97-102.
34. George C, Byass OR, Cast JE. Interventional radiology in the management of malignant biliary obstruction. World J Gastrointest Oncol 2010;2:146-150.
35. Chen Y, Wang XL, Yan ZP, Cheng JM, Wang JH, Gong GQ, et al. HDR-192Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice. World J Gastroenterol 2004;10:3506-3510. (Pubitemid 39549554)
36. Dvorak J, Jandik P, Melichar B, Jon B, Mergancova J, Zoul Z, et al. Intraluminal high dose rate brachytherapy in the treatment of bile duct and gallbladder carcinomas. Hepatogastroenterology 2002;49:916-917. (Pubitemid 34809748)
37. Nguyen-Tang T, Binmoeller KF, Sanchez-Yague A, Shah JN. Endoscopic ultrasound (EUS)-guided transhepatic anterograde self-expandable metal stent (SEMS) placement across malignant biliary obstruction. Endoscopy 2010;42:232-236.
38. Eisenhauer E, Therasse P, Bogaerts J, Schwartz L, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228-247.